New role for natural killers

Aug 27, 2008

Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer.

Natural Killer (or NK) cells are abundant white blood cells that were recognised over 30 years ago as being able to kill cancer cells in the test tube. Since that time, a role for NK cells in activating other white blood cells (including 'T' lymphocytes and phagocytes) and in directing how the immune system responds to a wide range of infections has also been established.

Because of these properties, NK have been widely regarded as being of benefit in the fight against cancer and infection, and methods to increase NK cell activity underpin a range of new experimental anti-cancer drugs and anti-infectives.

However, a research team in the University's Centre for Immunology and Infection and led by Professor Paul Kaye, has now demonstrated that NK cells also make chemicals that inhibit immune responses.

The research, published in the latest issue of the journal Immunity, has shown that in an experimental model of the tropical disease visceral leishmaniasis, too many NK cells can actually make the disease worse. They have identified that NK cells produce a chemical called interleukin-10 that can counteract many of the otherwise beneficial effects of these cells.

Professor Kaye said: "Other researchers have suggested in the past that NK cells might not always be good for you, but we now have the first direct evidence that this can actually be the case. Although we have worked on an infectious disease, the same is likely to be true for NK cells in cancer. So, in practical terms, it means that we need to consider more carefully exactly how we use therapies that affect NK cells, to maximize their beneficial role."

The new findings also open up the potential of developing new drugs that specifically target the beneficial properties of NK cells, and which leave their inhibitory properties switched off. Conversely, in autoimmune diseases, where the immune system is too active, it may be possible to stimulate NK cells to turn it off.

Source: University of York

Explore further: Researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies

add to favorites email to friend print save as pdf

Related Stories

'Work environment' affects protein properties

Jul 03, 2014

The function of proteins, which fulfil various tasks inside the cells, is often analysed in aqueous buffer solutions. However, it is not known, for example in case of pharmaceutical studies, if they work ...

Smart gating nanochannels for confined water developed

Jun 25, 2014

Confined water exists widely and plays important roles in natural environments, particularly inside biological nanochannels. Professor Lei Jiang and his group from State Key Laboratory of Organic Solids, ...

Building synthetic plants

Jun 20, 2014

A movement is under way that will fast-forward the design of new plant traits. It takes inspiration from engineering and the software industry, and is being underpinned in Cambridge and Norwich by an initiative ...

Recommended for you

Immune response may cause harm in brain injuries, disorders

1 hour ago

Could the body's own immune system play a role in memory impairment and cognitive dysfunction associated with conditions like chronic epilepsy, Alzheimer's dementia and concussions? Cleveland Clinic researchers believe so, ...

One route to malaria drug resistance found

4 hours ago

Researchers have uncovered a way the malaria parasite becomes resistant to an investigational drug. The discovery, at Washington University School of Medicine in St. Louis, also is relevant for other infectious ...

Protein therapy successful in treating injured lung cells

5 hours ago

Cardiovascular researchers at The Ohio State University Wexner Medical Center have successfully used a protein known as MG53 to treat acute and chronic lung cell injury. Additionally, application of this protein proved to ...

User comments : 0